RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Hepatitis

A collection of news and information related to Hepatitis published by this site and its partners.

Top Hepatitis Articles see all

Displaying items 1-5
  • The $84,000 hepatitis drug [Letter]

    It was interesting to read that there is now a cure for hepatitis C in the form of new drugs that are capable of completely suppressing the virus in 90 percent of patients in 8 to 12 weeks ("Gilead Sciences' $84,000 price for hepatitis drug is scrutinized," March 21).
  • U.S. senators ask Gilead Sciences to explain high cost of hepatitis C drug

    Two U.S. senators asked Gilead Sciences Inc. to produce documents explaining why its new hepatitis C drug is priced at $84,000 per treatment course, raising renewed concerns over the high costs to taxpayers. In a letter sent Friday, Ron Wyden (D-Ore.)...

    Another Obamacare goal: Spend money on prevention, save money on cure

    Another Obamacare goal: Spend money on prevention, save money on cure
    Randy Gutzke, a longtime IV drug user who says he struggles daily to stay sober, recently was offered a quick-results test for hepatitis C at a West Side community health center. A case manager also reviewed the behaviors that put him at risk for...

    Despite ridicule, Egypt pushes ahead with AIDS, hepatitis 'cure'

    Egypt’s military on Saturday pressed ahead with promotion of a fanciful device it claims can diagnose and cure AIDS and hepatitis, announcing that it would be tested in the next six months on larger numbers of patients in army hospitals. It was...

    Travel abroad to solve the high cost of Hepatitis C medication

    The new Hepatitis C drug costs $84,000 for a 12-week course. In Egypt, it costs $900. Thousands of Americans go to other countries for low-cost medical procedures or treatments . Why don't the insurance companies send the Hepatitis C patients on a 12-week...